Oct 04, 2013 - 8:34 am
Tracon has closed the study trial on the TRC 105. Robert was the only one left out of 28 subjects, and the only one who has had a response (i.e. shrinkage).
They are "rolling" him over to a continuation of the trial, since he is responding, where he will be the only participant. Treatment will remain the same.
Last scan showed a tiny bit of shrinkage in the big tumor, and stable in all the rest of them. No new ones, either.
I wonder why Robert showed response, and no one else did.